失败Fontan循环的外科治疗:30例、285患者年随访结果
该单中心回顾性研究分析了1995至2020年间因Fontan循环失败接受外科治疗的30例患者(平均年龄24.7岁),手术方式包括Fontan转换、心脏移植及其他再手术。长期生存尚可,但早期和晚期并发症负担仍重,其他再手术死亡率高,建议尽早评估Fontan转换或心脏移植。
要点
- Fontan失败外科治疗远期生存尚可,但术后心律失常和Fontan相关肝病常见。
- 心脏移植与Fontan转换预后相当,不适宜移植者行其他再手术死亡率高。
- 应密切随访,尽早评估Fontan转换或心脏移植以优化结局。
核心结论
- 失败Fontan的外科治疗可有效实施,总体长期生存良好,但早期和晚期并发症仍是显著负担。
- 因存在心脏移植禁忌而接受其他再手术的患者死亡率高,建议密切临床随访并尽早评估Fontan转换或心脏移植。
研究设计与样本
- 单中心回顾性分析,纳入1995至2020年因Fontan循环失败接受外科治疗的患者30例,平均年龄24.7岁。
- 手术方式包括心室功能保留时的各类再手术,心室收缩功能受损时的心脏移植(HTx)。
- 分析生存率、手术指征及早期和晚期并发症发生率。
主要发现
- 距原Fontan手术平均19.3年后需手术,Fontan转换21例(70%,其中心外管道19例、侧隧道2例),心脏移植4例(13.3%),其他再手术5例(16.7%)。
- 最常见手术指征为快速性心律失常(63.3%)和严重右心房扩张(63.3%)。
- 1年、5年、10年和20年总生存率分别为75.9%(95%CI:91.4-60.4%)、75.9%(95%CI:91.4-60.4%)、70%(95%CI:78-52%)和70%(95%CI:78-52%)。
- 最常见并发症为术后快速性心律失常(50%)和晚期Fontan相关肝病(56.5%)。
- 心脏移植和Fontan转换与其他再手术相比结局相当良好(P=0.022)。
临床怎么用
- 对Fontan循环失败患者应密切临床随访,尽早评估Fontan转换或心脏移植以优化结局。
- 对存在心脏移植禁忌而需其他再手术者应警惕高死亡率。
局限性
- 单中心回顾性研究,样本量30例,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Fontan patients are known to suffer from clinical attrition over the years, which has been characterized as Fontan failure. We sought to evaluate the clinical outcomes of such Fontan patients undergoing surgical management in a 25-year, single-centre experience. METHODS: A retrospective single-centre analysis of patients undergoing surgical treatment for failing Fontan between 1995 and 2020, including any reoperations when ventricular function was preserved, or a heart transplant (HTx), when ventricular contractility was impaired. We analysed survival, indications for surgery and early and late complication rates. RESULTS: We collected 30 patients (mean age 24.7 years) who required surgery after a mean time of 19.3 years from the original Fontan procedure: Fontan conversion in 21 (70%, extracardiac conduit in 19, lateral tunnel in 2), a HTx in 4 (13.3%) and other reoperations in 5 (16.7%). The most common indications for surgery were tachyarrhythmias (63.3%) and severe right atrial dilatation (63.3%). Overall survival at the 1-, 5-, 10- and 20-year follow-up examinations were 75.9% [95% confidence interval (CI): 91.4-60.4%], 75.9% (95% CI: 91.4-60.4%), 70% (95% CI: 78-52%) and 70% (95% CI: 78-52%), respectively. The most frequent complications were postoperative tachyarrhythmias (50%) and late Fontan-associated liver disease (56.5%). HTx and Fontan conversion provided comparably good outcomes compared to other reoperations (P = 0.022). CONCLUSIONS: Surgery for failing Fontan can be performed effectively with overall good long-term survival. However, early and late morbidities are still a significant burden. Because other reoperations performed when patients presented with contraindications for a HTx have carried high mortality, close clinical follow-up is mandatory, and an earlier indication for Fontan conversion or a HTx is advisable to optimize outcomes.
引用
- Padalino MA, Ponzoni M, Castaldi B, et al. Surgical management of failing Fontan circulation: results from 30 cases with 285 patient-years follow-up. Eur J Cardiothorac Surg. 2022. PMID: 34687535. doi:10.1093/ejcts/ezab450
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。